Literature DB >> 21389253

IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.

Floriana Berretta1, Jessica St-Pierre, Ciriaco A Piccirillo, Mary M Stevenson.   

Abstract

To investigate the role of CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells in blood-stage malaria, we compared Plasmodium chabaudi AS infection in wild-type (WT) C57BL/6 and transgenic mice overexpressing the transcription factor Foxp3 (Foxp3Tg) and observed that Foxp3Tg mice experienced lethal infection and deficient malaria-specific immune responses. Adoptive transfer of total CD4(+) T cells from Foxp3Tg mice or CD4(+)CD25(+) T cells from WT mice to naive WT recipients confirmed that high numbers of Treg cells compromised immune control of malaria. Transfer of GFP(+)CD4(+)CD25(+) T cells to naive WT recipients together with immunohistochemical staining of spleens from infected WT mice demonstrated that Foxp3(+) Treg cells localized in the T cell area of the spleen. Determination of CD4(+)Foxp3(+) Treg cell responses in the spleen of infected WT mice revealed a significant but transient increase in CD4(+)Foxp3(+) Treg cells early in infection. This was followed by a significant and sustained decrease due to reduced proliferation and apoptosis of CD4(+)Foxp3(+) Treg cells. Importantly, the kinetics of IL-2 secretion by effector CD4(+)Foxp3(-) T cells coincided with changes in CD4(+)Foxp3(+) cells and the differentiation of CD4(+)T-bet(+)IFN-γ(+) cells required for immune control of infection. Administration of the IL-2/anti-IL-2 mAb (clone JES6-1) complex to infected WT mice increased the severity of P. chabaudi AS infection and promoted expansion of Foxp3(+) Treg cells. Collectively, these data demonstrate that the ability to control and eliminate P. chabaudi AS infection is due to a tight balance between natural Treg cells and effector CD4(+) Th1 cells, a balance regulated in part by IL-2.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389253     DOI: 10.4049/jimmunol.1003777

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10.

Authors:  Yang Cheng; Bo Wang; Jetsumon Sattabongkot; Chae Seung Lim; Takafumi Tsuboi; Eun-Taek Han
Journal:  Parasitol Res       Date:  2014-04-25       Impact factor: 2.289

2.  Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.

Authors:  Steven Kho; Jutta Marfurt; Rintis Noviyanti; Andreas Kusuma; Kim A Piera; Faustina H Burdam; Enny Kenangalem; Daniel A Lampah; Christian R Engwerda; Jeanne R Poespoprodjo; Ric N Price; Nicholas M Anstey; Gabriela Minigo; Tonia Woodberry
Journal:  Infect Immun       Date:  2015-06-01       Impact factor: 3.441

Review 3.  The contribution of Plasmodium chabaudi to our understanding of malaria.

Authors:  Robin Stephens; Richard L Culleton; Tracey J Lamb
Journal:  Trends Parasitol       Date:  2011-11-17

4.  CD4+ T cell response correlates with naturally acquired antibodies against Plasmodium vivax tryptophan-rich antigens.

Authors:  Mohammad Zeeshan; Kriti Tyagi; Yagya D Sharma
Journal:  Infect Immun       Date:  2015-03-02       Impact factor: 3.441

Review 5.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

6.  Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory response.

Authors:  Xiyue He; Juan Yan; Xiaotong Zhu; Qinghui Wang; Wei Pang; Zanmei Qi; Meilian Wang; Enjie Luo; Daniel M Parker; Margherita T Cantorna; Liwang Cui; Yaming Cao
Journal:  J Immunol       Date:  2014-06-25       Impact factor: 5.422

7.  HLA class II (DR0401) molecules induce Foxp3+ regulatory T cell suppression of B cells in Plasmodium yoelii strain 17XNL malaria.

Authors:  Wathsala Wijayalath; Rebecca Danner; Yuliya Kleschenko; Sai Majji; Eileen Franke Villasante; Thomas L Richie; Teodor-Doru Brumeanu; Chella S David; Sofia Casares
Journal:  Infect Immun       Date:  2013-10-28       Impact factor: 3.441

Review 8.  Using two phases of the CD4 T cell response to blood-stage murine malaria to understand regulation of systemic immunity and placental pathology in Plasmodium falciparum infection.

Authors:  Komi Gbedande; Victor H Carpio; Robin Stephens
Journal:  Immunol Rev       Date:  2020-01       Impact factor: 12.988

Review 9.  Application of IL-2 therapy to target T regulatory cell function.

Authors:  Ethan M Shevach
Journal:  Trends Immunol       Date:  2012-08-30       Impact factor: 16.687

10.  Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response.

Authors:  Chiara Camisaschi; Paola Filipazzi; Marcella Tazzari; Chiara Casati; Valeria Beretta; Lorenzo Pilla; Roberto Patuzzo; Andrea Maurichi; Agata Cova; Michele Maio; Vanna Chiarion-Sileni; Gabrina Tragni; Mario Santinami; Barbara Vergani; Antonello Villa; Emilio Berti; Ludmila Umansky; Philipp Beckhove; Viktor Umansky; Giorgio Parmiani; Licia Rivoltini; Chiara Castelli
Journal:  Cancer Immunol Immunother       Date:  2013-04-16       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.